I am a PhD candidate in the Computer Science department at Stanford University. My interests include a wide variety of topics at the intersection of computer science, biology, and medicine, such as rare genetic variation, the heritability of complex traits, and regulatory genomics.

In 2016, I received a B.S. in Computer Science, with honors, from Stanford University. Before my work in genomics, I worked as a production assistant at Four Directions Productions. I also worked as a software engineer for the Python Software Foundation, Yahoo! Research - Latin America, and Facebook.


Publications

Independent erosion of conserved transcription factor binding sites points to shared hindlimb, vision, and scrotum loss in different mammals

Mark J. Berger, Aaron M. Wenger, Harendra Guturu, Gill Bejerano
bioRxiv
[pdf]
Comment on "A genetic signature of the evolution of loss of flight in the Galapagos cormorant"

Mark J. Berger, Gill Bejerano
bioRxiv
[pdf]

M-CAP eliminates majority of variants of uncertain significance in clinical exomes at 95% sensitivity

Karthik A. Jagadeesh*, Aaron M. Wenger*, Mark J. Berger, Harendra Guturu, Peter D. Stenson, David N. Cooper, Jonathan A. Bernstein, Gill Bejerano
Nature Genetics
[pdf] [project page]

Research Experience

Curtis Lab, April 2016 - September 2016

In the Curtis Lab, I studied a subtype of breast cancer using next-generation sequencing technologies. This included a wide variety of methods, such as whole-genome sequencing, copy number assays, and RNA-seq.

Bejerano Lab, April 2015 - June 2016

In the Bejerano Lab, I worked on tools which help research scientists and clinical geneticists diagnose patients with rare genetic diseases. Oftentimes, doctors cannot properly diagnose a child with rare genetic defects. Therefore, the doctor will sequence the protein-coding portion of the child's DNA to see if the patient harbors any known disease-causing mutations. If the child does not carry a known disease-causing mutation, the clinician must examine a list of 300 to 500 variants which might be causing the disease. During my time in the Bejerano Lab, I worked on tools which help to reduce this list of uncertain variants.